Teladoc Health has come under pressure after Cantor Fitzgerald reiterated its commodity-like outlook on telehealth. Analysts Steven Halper and Kyle Mikson reaffirm their neutral rating on the stock with a price target of $210.00 per share to imply a ~21.8% upside to the last close. The duo cites a Wall Street Journal article in which Erik Sossa former head of benefits at Pepsico indicated that ‘telehealth is kind of a commodity.’
COVID-19 let virtual medicine out of the bottle. Now it’s time to tame it. If we don't, there is a danger that it will stealthily become a mainstay of our medical care. Deploying it too widely or too quickly risks poorer care, inequities and even more outrageous charges in a system already infamous for big bills.
Make telemedicine your first choice for most doctor visits. That’s the message some U.S. employers and insurers are sending with a new wave of care options. Amazon and several insurers have started or expanded virtual-first care plans to get people to use telemedicine routinely, even for planned visits like annual checkups. They’re trying to make it easier for patients to connect with regular help by using remote care that grew explosively during the COVID-19 pandemic.